A comparison of intravenous ibuprofen 800mg, parecoxib 40mg, parecoxib 80mg and placebo in female patients undergoing hysteroscopy +/- dilatation and curettage +/- mirena insertion as day case surgery - a comparison of analgesic efficacy, quality of recovery and incidence of opioid related side effects

Next Previous
Trial Profile

A comparison of intravenous ibuprofen 800mg, parecoxib 40mg, parecoxib 80mg and placebo in female patients undergoing hysteroscopy +/- dilatation and curettage +/- mirena insertion as day case surgery - a comparison of analgesic efficacy, quality of recovery and incidence of opioid related side effects

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Ibuprofen (Primary) ; Parecoxib (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms DEFINITIVE

    • Most Recent Events

    • 31 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top